Moneycontrol
HomeNewsBusinessEarningsIdeas for profit | Lupin: Focus on inhalation & biosimilars to aid margins in medium term
Trending Topics

Ideas for profit | Lupin: Focus on inhalation & biosimilars to aid margins in medium term

Possibility of positive developments on the product pipeline front and restructuring initiatives can accelerate earnings growth for Lupin. We continue to believe this opportunity is more suitable for investors with high risk appetite and those who are ready to hold it long enough for the product pipeline to unfold

May 14, 2021 / 18:07 IST
Story continues below Advertisement

Moneycontrol News
first published: May 14, 2021 06:07 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!